Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL SELF-MONITORING BLOOD GLUCOSE SYSTEM INDUSTRY
2.1 Summary about Self-Monitoring Blood Glucose System Industry
2.2 Self-Monitoring Blood Glucose System Market Trends
2.2.1 Self-Monitoring Blood Glucose System Production & Consumption Trends
2.2.2 Self-Monitoring Blood Glucose System Demand Structure Trends
2.3 Self-Monitoring Blood Glucose System Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Blood Glucose meters
4.2.2 Testing strips
4.2.3 Lancets & Lancing Devices
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Type 2 Diabetes
4.3.2 Type 1 Diabetes
4.3.3 Gestational Diabetes
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Blood Glucose meters
5.2.2 Testing strips
5.2.3 Lancets & Lancing Devices
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Type 2 Diabetes
5.3.2 Type 1 Diabetes
5.3.3 Gestational Diabetes
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Blood Glucose meters
6.2.2 Testing strips
6.2.3 Lancets & Lancing Devices
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Type 2 Diabetes
6.3.2 Type 1 Diabetes
6.3.3 Gestational Diabetes
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Blood Glucose meters
7.2.2 Testing strips
7.2.3 Lancets & Lancing Devices
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Type 2 Diabetes
7.3.2 Type 1 Diabetes
7.3.3 Gestational Diabetes
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Blood Glucose meters
8.2.2 Testing strips
8.2.3 Lancets & Lancing Devices
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Type 2 Diabetes
8.3.2 Type 1 Diabetes
8.3.3 Gestational Diabetes
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Blood Glucose meters
9.2.2 Testing strips
9.2.3 Lancets & Lancing Devices
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Type 2 Diabetes
9.3.2 Type 1 Diabetes
9.3.3 Gestational Diabetes
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Roche (Switzerland)
10.1.2 Abbott (US)
10.1.3 LifeScan (US)
10.1.4 Ascensia (Switzerland)
10.1.5 Medtronic (Ireland), Dexcom (US)
10.1.6 Ypsomed (Switzerland)
10.1.7 B. Braun (Germany)
10.1.8 Nipro (Japan), Sanofi (France)
10.1.9 ARKRAY (Japan)
10.1.10 Prodigy Diabetes Care (US)
10.1.11 ACON Laboratories (US)
10.1.12 Nova Biomedical (US)
10.2 Self-Monitoring Blood Glucose System Sales Date of Major Players (2017-2020e)
10.2.1 Roche (Switzerland)
10.2.2 Abbott (US)
10.2.3 LifeScan (US)
10.2.4 Ascensia (Switzerland)
10.2.5 Medtronic (Ireland), Dexcom (US)
10.2.6 Ypsomed (Switzerland)
10.2.7 B. Braun (Germany)
10.2.8 Nipro (Japan), Sanofi (France)
10.2.9 ARKRAY (Japan)
10.2.10 Prodigy Diabetes Care (US)
10.2.11 ACON Laboratories (US)
10.2.12 Nova Biomedical (US)
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
1.Table Self-Monitoring Blood Glucose System Product Type Overview
2.Table Self-Monitoring Blood Glucose System Product Type Market Share List
3.Table Self-Monitoring Blood Glucose System Product Type of Major Players
4.Table Brief Introduction of Roche (Switzerland)
5.Table Brief Introduction of Abbott (US)
6.Table Brief Introduction of LifeScan (US)
7.Table Brief Introduction of Ascensia (Switzerland)
8.Table Brief Introduction of Medtronic (Ireland), Dexcom (US)
9.Table Brief Introduction of Ypsomed (Switzerland)
10.Table Brief Introduction of B. Braun (Germany)
11.Table Brief Introduction of Nipro (Japan), Sanofi (France)
12.Table Brief Introduction of ARKRAY (Japan)
13.Table Brief Introduction of Prodigy Diabetes Care (US)
14.Table Brief Introduction of ACON Laboratories (US)
15.Table Brief Introduction of Nova Biomedical (US)
16.Table Products & Services of Roche (Switzerland)
17.Table Products & Services of Abbott (US)
18.Table Products & Services of LifeScan (US)
19.Table Products & Services of Ascensia (Switzerland)
20.Table Products & Services of Medtronic (Ireland), Dexcom (US)
21.Table Products & Services of Ypsomed (Switzerland)
22.Table Products & Services of B. Braun (Germany)
23.Table Products & Services of Nipro (Japan), Sanofi (France)
24.Table Products & Services of ARKRAY (Japan)
25.Table Products & Services of Prodigy Diabetes Care (US)
26.Table Products & Services of ACON Laboratories (US)
27.Table Products & Services of Nova Biomedical (US)
28.Table Market Distribution of Major Players
29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
31.Table Global Self-Monitoring Blood Glucose System Market Forecast (Million USD) by Region 2021f-2026f
32.Table Global Self-Monitoring Blood Glucose System Market Forecast (Million USD) Share by Region 2021f-2026f
33.Table Global Self-Monitoring Blood Glucose System Market Forecast (Million USD) by Demand 2021f-2026f
34.Table Global Self-Monitoring Blood Glucose System Market Forecast (Million USD) Share by Demand 2021f-2026f